ArticleFrontiers in medicine2022

Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study.

Mohammad Shehab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.